C0025663||method
C0220825||assessment
C1457887||dysarthrophonia
C0026896||myasthenia gravis
C0037817||Speech
C0042939||voice
C1457887||symptomatology
C1457887||dysarthrophonia
C0026896||myasthenia gravis
C0026896||myasthenia gravis
C0025663||methods
C0220825||assessment
C1457887||dysarthrÎ¿phonia
C0220825||evaluation
C0026896||myasthenia gravis
C1457887||symptoms
C0018017||goal
C0031577||phonatory
C0031577||phonation
C0037817||speech
C0278157||diadochokinesis
C0031843||function
C0026896||myasthenia gravis
C0042939||voice
C0037817||speech
C0026896||myasthenia gravis
C0236516||anti-AchR
C3203598||anti-MuSK antibodies
C1096366||electroglottography
C1096366||electroglottography
C0042939||voice
C0026896||myasthenia gravis
C0042930||vibrating vocal folds
C0278157||diadochokinesis
C0026896||myasthenia gravis
C0026896||myasthenia gravis
C1515021||subgroups
C0236516||anti-AchR
C3203598||anti-MuSK antibodies
C2603343||study
C0025663||methods
C1096366||electroglottography
C0220825||assessment
C1457887||dysarthrophonia
C0026896||myasthenia gravis